share_log

Nexalin Technology, Inc. (NASDAQ:NXL) CFO Purchases $10,640.00 in Stock

Nexalin Technology, Inc. (NASDAQ:NXL) CFO Purchases $10,640.00 in Stock

耐克林科技股份有限公司（納斯達克：NXL）首席財務官購買 10,640.00 美元的股票
kopsource ·  2022/09/29 14:33

$Nexalin Technology (NXL.US)$ CFO Marilyn Elson purchased 9,500 shares of the firm's stock in a transaction that occurred on Wednesday, September 28th. The stock was purchased at an average price of $1.12 per share, with a total value of $10,640.00. Following the purchase, the chief financial officer now directly owns 835,244 shares of the company's stock, valued at $935,473.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

$Nexalin Technology (NXL.US)$首席財務官瑪麗蓮·埃爾森購買 9,500 該公司股票的股票在發生在週三的交易, 9 月 28 日.該股票以每股 1.12 美元的平均價格購買，總價值為 10,640.00 美元。購買後，首席財務官現在直接擁有該公司股票的 835,244 股，價值 935,473.28 美元。該交易在與證券交易委員會的法律文件中披露，該交易可通過以下方式獲得 此超連結。

About Nexalin Technology

關於耐克林科技

Nexalin Technology, Inc, a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders.

Nexalin Technology, Inc 是一家醫療器械公司，在美國和中國設計和開發用於治療心理健康的神經刺激產品。它許可證和市場 Nexalin 設備, 非侵入性和無藥物治療焦慮和失眠的治療.該公司的 Nexalin 設備發射了基於頻率的專利波形，從而刺激與各種心理健康疾病相關的腦中結構的積極反應。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論